• Intellia, Regeneron, Viatris + Oyster Point

  • 2022/11/16
  • 再生時間: 10 分
  • ポッドキャスト

Intellia, Regeneron, Viatris + Oyster Point

  • サマリー

  • More CRISPR data, oncology wins, and a new player in ophthalmology

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Intellia
    Regeneron
    Viatris + Oyster Point

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示

あらすじ・解説

More CRISPR data, oncology wins, and a new player in ophthalmology

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Intellia
Regeneron
Viatris + Oyster Point

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Intellia, Regeneron, Viatris + Oyster Pointに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。